Variation site of hypertension susceptibility gene Mfn2 and detecting method of variation site
A technology of essential hypertension and loci, applied in the fields of molecular biology and medicine, can solve the problems of decreased expression, abnormal expression regulation, and less research.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] The region between -2517 and -2518 of the 5' non-coding region of the essential hypertension susceptibility gene MFn2 gene was detected by sequencing. 30 cases of each of the above-mentioned hypertension cases and control groups were selected for sequencing to determine the genotype of the region between -2517 and -2518 in the 5' non-coding region.
[0029] 1. Experimental method
[0030] The above PCR primers were still used as primers for PCR sequencing, and the amplified products were directly sequenced after purification. The sequencing instrument is ABI's 3130xl genetic analyzer, which is analyzed with sequenceanalysis5.2 analysis software, and the results can also be viewed with chromas.
[0031] 2. Experimental results
[0032] The screenshot of the sequencing result is as follows: figure 1 shown.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com